Hims & Hers vs Ro

What each one charges

Medication only. Both companies bill the membership separately, and neither membership includes any medicine.

Hims & Hers

Semaglutide

$199 /mo

Wegovy pen, medication only

Tirzepatide

$299 /mo

Zepbound KwikPen or vial, medication only. Hims sells no Mounjaro

Membership

Membership only. $39 for the first month, then $149 a month. Medication is charged separately and there is no medication without the membership

Ro

Semaglutide

$199 /mo

Wegovy pen, against a $1,349 list price

Tirzepatide

$299 /mo

Zepbound KwikPen, against a $1,087 list price

Membership

Membership only. $39 for the first month, then $74 to $149 a month depending on the plan. Medication is charged separately

Where they differ

Each line is one criterion. A line that names a company names it on that criterion only. Nothing here says which provider anybody should choose.

• Tirzepatide, per month

  No difference

  Both list the Zepbound KwikPen at $299 a month against a $1,087 list price, and Hims & Hers sells the vial at the same price. Neither figure includes the membership. Hims & Hers listed both at more than six times that in August 2026 and no longer sells Mounjaro at any price, so this reading favoured Ro until 16 September 2026 and now favours neither.

• Semaglutide, per month

  No difference

  Both list the Wegovy pen at $199 a month, medication only. Ro states its cash prices match LillyDirect, NovoCare and TrumpRx.

• What the membership costs after the first month

  Ro

  Both open at $39. After that Hims & Hers is $149 a month and Ro is $74 to $149 depending on the plan. Neither $39 includes any medication, and Hims & Hers sells no medication at all without the membership.

• Which pharmacy dispenses

  Hims & Hers

  Hims & Hers states in its annual report that most prescriptions are filled by pharmacies it owns outright, plus contracted partners. Ro does not name a dispensing pharmacy on the pages read.

• Compounding

  No difference

  Hims & Hers compounds as well as selling branded, and states in its 10-K that it uses 503A pharmacies only. Ro sells branded medicine and does not compound. Neither fact is a safety finding on its own; it decides what is legally in the vial.

• Open regulatory matters

  Ro

  Hims & Hers discloses two FDA warning letters from September 2025 about statements on its websites regarding compounded semaglutide, an SEC investigation into its public statements on the same subject, and patent litigation brought by Novo Nordisk. These are the companys own disclosures in its filings. We found no equivalent disclosures for Ro.

• LegitScript certification

  No difference

  Both are certified. Ro serves its seal, number 3722005, from its own pages, and it returns 200 from LegitScript while an invented number returns 403.

• Price shown before the intake form

  No difference

  Both show full prices before asking for any health information. That is not the norm in this category and it is why both could be priced at all.

The same five checks, both companies

Checked by hand on each company's own pages. A hatched cell means nobody has confirmed it yet, which is not the same as a no.

• Dispensing pharmacy

  Hims & Hers

  503A

  Ro

  retail

• LegitScript certified

  Hims & Hers

  Yes

  Ro

  Yes

• Price shown before intake

  Hims & Hers

  Yes

  Ro

  Yes

• Cancel online

  Hims & Hers

  Yes

  Ro

  Yes

• Prescriber disclosed

  Hims & Hers

  Yes

  Ro

  none published

The full audit for each

Referral fee if you use our link to Ro, and nothing by Hims & Hers. It never changes what you pay and it cannot change what our audit found. How we make money

Hims & Hers

Publicly listed telehealth. Compounds through its own 503A pharmacies

Read the audit

Ro

Vertically integrated telehealth, NovoCare and LillyDirect partnerships

See Ro pricing (opens in a new tab, we are paid a referral fee) Read the audit